Zai Lab Ltd
HKEX:9688
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zai Lab Ltd
HKEX:9688
|
CN |
|
Delta Lithium Ltd
ASX:DLI
|
AU |
|
Smith & Nephew PLC
LSE:SN
|
UK |
|
J
|
Jones Lang LaSalle Inc
XBER:4J2
|
US |
|
Ezenia! Inc
OTC:EZEN
|
US |
|
H
|
Henry Schein Inc
F:HS2
|
US |
|
Marsh & McLennan Companies Inc
NYSE:MMC
|
US |
|
Resmed Inc
OTC:RSMDF
|
US |
|
T
|
TriMas Corp
NASDAQ:TRS
|
US |
|
Japan Excellent Inc
TSE:8987
|
JP |
|
Ardelyx Inc
NASDAQ:ARDX
|
US |
|
COG Financial Services Ltd
ASX:COG
|
AU |
|
Daehan Shipbuilding Co Ltd
KRX:439260
|
KR |
|
Bridgepoint Group PLC
LSE:BPT
|
UK |
|
Kinarus Therapeutics Holding AG
SIX:KNRS
|
CH |
|
Skeena Resources Ltd
TSX:SKE
|
CA |
|
Carter's Inc
NYSE:CRI
|
US |
|
B
|
Barrick Gold Corp
LSE:0R22
|
CA |
|
Somero Enterprises Inc
LSE:SOM
|
US |
|
D
|
Deep Yellow Ltd
XMUN:JMI
|
AU |
|
Lithia Motors Inc
NYSE:LAD
|
US |
|
P
|
PTC Therapeutics Inc
DUS:BH3
|
US |
|
PetroChina Co Ltd
SSE:601857
|
CN |
|
C
|
Canadian Tire Corporation Ltd
F:YAAA
|
CA |
Bankruptcy Probability
Zai Lab Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Zai Lab Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
Zai Lab Ltd
HKEX:9688
|
15.1B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Zai Lab Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Zai Lab Ltd has total debt of 213.8m USD. This includes both short-term (213.8m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
